TREA

90474748 - GALXC PLUS

Follow

Information

  • Trademark
  • 90474748
  • Serial Number
    90474748
  • Filing Date
    January 19, 2021
    4 years ago
  • Transaction Date
    September 12, 2024
    4 months ago
  • Status Date
    September 12, 2024
    4 months ago
  • Published for Opposition Date
    January 16, 2024
    a year ago
  • Location Date
    March 12, 2024
    10 months ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    MACDOUGALL, KIERRA
  • Attorney Name
    Bridget H. Labutta
    Law Office Assigned Location Code
    N80
  • Owners
Information
Mark Drawing Code
3
Mark Identification
GALXC PLUS
Case File Statements
  • DM0000: The mark consists of the words "GALXC PLUS" in stylized font, with "GAL" and "PLUS" in blue title font and "XC" in enlarged orange capital letters. The orange letter "X" in "GALXC PLUS" is partially composed of a repeating pattern of light, medium and dark orange shaded triangles.
  • GS0051: Oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNA interference (RNAi) therapy; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents intravenously or subcutaneously for use in targeted pharmaceutical therapies for a wide range of medical purposes; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
  • PM0001: GALAXY PLUS
  • CC0000: The color(s) blue and orange is/are claimed as a feature of the mark.
  • GS0421: Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections; research and development of pharmaceutical preparations for the treatment of disorders outside the liver; research and development of oligonucleotide compounds for targeted gene silencing; research and development of oligonucleotide drug delivery platforms for use in the treatment of rare diseases, genetic disorders, cardiovascular diseases, and viral infections
Case File Event Statements
  • 1/22/2021 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/25/2021 - 3 years ago
    2 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 2/25/2021 - 3 years ago
    3 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/25/2021 - 3 years ago
    4 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/20/2021 - 3 years ago
    5 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/20/2021 - 3 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/27/2021 - 3 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/27/2021 - 3 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/27/2021 - 3 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/12/2021 - 3 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/12/2021 - 3 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/12/2021 - 3 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/31/2021 - 3 years ago
    13 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 8/31/2021 - 3 years ago
    14 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 8/31/2021 - 3 years ago
    15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 1/5/2022 - 3 years ago
    16 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 1/5/2022 - 3 years ago
    17 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/5/2022 - 3 years ago
    18 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/5/2022 - 3 years ago
    19 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/5/2022 - 3 years ago
    20 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/13/2022 - 3 years ago
    21 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/13/2022 - 3 years ago
    22 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/13/2022 - 3 years ago
    23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/2/2022 - 2 years ago
    24 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/2/2022 - 2 years ago
    25 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/2/2022 - 2 years ago
    26 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/7/2022 - 2 years ago
    27 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 5/25/2022 - 2 years ago
    28 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 5/25/2022 - 2 years ago
    29 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/25/2022 - 2 years ago
    30 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/7/2022 - 2 years ago
    31 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 2/7/2023 - a year ago
    32 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/7/2023 - a year ago
    33 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/7/2023 - a year ago
    34 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/6/2023 - a year ago
    35 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 5/11/2023 - a year ago
    36 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/11/2023 - a year ago
    37 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/11/2023 - a year ago
    38 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/10/2023 - a year ago
    39 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 8/10/2023 - a year ago
    40 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 11/10/2023 - a year ago
    41 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 11/10/2023 - a year ago
    42 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/10/2023 - a year ago
    43 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/13/2023 - a year ago
    44 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/27/2023 - a year ago
    45 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/16/2024 - a year ago
    46 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/16/2024 - a year ago
    47 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/12/2024 - 4 months ago
    49 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 9/12/2024 - 4 months ago
    52 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 9/12/2024 - 4 months ago
    50 - SOU EXTENSION 1 FILED Type: EXT1
  • 9/12/2024 - 4 months ago
    51 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 3/12/2024 - 10 months ago
    48 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM